Last reviewed · How we verify
NCT03305328
Assessing the Clinical Utility of tACS
NA trial testing Transcranial Alternating Current Stimulation in Anxiety Disorders and Symptoms in 38 participants. Completed in 31 March 2017.
31 March 2017
Quick facts
| Lead sponsor | Florida State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 38 |
| Start date | 29 July 2016 |
| Primary completion | 31 March 2017 |
| Estimated completion | 31 March 2017 |
Drugs / interventions tested
- Transcranial Alternating Current Stimulation
Conditions studied
- Anxiety Disorders and Symptoms — all drugs for Anxiety Disorders and Symptoms →
- Sensory Disorders — all drugs for Sensory Disorders →
- Hypervigilance — all drugs for Hypervigilance →
- Post Traumatic Stress Disorder — all drugs for Post Traumatic Stress Disorder →
Sponsor
Florida State University
Who can join
Adults 18 to 60, any sex, with Anxiety Disorders and Symptoms or Sensory Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study seeks to evaluate the clinical utility of repeated transcranial alternating current stimulation (tACS) by assessing long-term, lasting changes in oscillatory activity and subsequent changes in related behavioral processes of anxious arousal and sensory sensitivity. To date, only transient effects of tACS have been reported, lasting no longer than 30 to 70 minutes. In order to be truly impactful within a clinical setting, however, evidence for long-term effects of tACS is needed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03305328
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcranial Alternating Current Stimulation
Trials testing the same drug.
- NCT06873750 — Neuromodulation and FMRI in Neurodegenerative Diseases Study · NA · not yet recruiting
- NCT07323407 — Transcranial Alternating Current Stimulation for Refractory Constipation With Somatic Symptom Disorder · NA · recruiting
- NCT07045584 — Temporal Pole Transcranial Alternating Current Stimulation for Children With Autism Spectrum Disorder · NA · completed
- NCT06733714 — Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in · NA · recruiting
- NCT06558890 — Transcranial Electrical Stimulation Targeting the Cerebellum for the Treatment of Refractory Temporal Lobe Epilepsy · NA · recruiting
Other recruiting trials for Anxiety Disorders and Symptoms
Currently open trials in the same condition.
- NCT05067998 — The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature · recruiting
- NCT05821634 — Personalizing Treatment Delivery · NA · recruiting
- NCT06138730 — Evaluating a Virtual Mentoring Program Plus Mental Health Videos for Teens · NA · active not recruiting
- NCT06356090 — SPACE: a Parent-based Treatment for Pediatric OCD · NA · recruiting
- NCT05836090 — Family Spirit Strengths · NA · recruiting
Other Florida State University trials
Trials by the same sponsor.
- NCT06127914 — Learning Early Infant Feeding Cues · NA · not yet recruiting
- NCT06015581 — Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida · NA · not yet recruiting
- NCT07467473 — Causal Role of Rostromedial Prefrontal Cortex for Positive Savoring in Depression · NA · enrolling by invitation
- NCT07221448 — Sodium vs Potassium Education to Improve Vascular Health · NA · recruiting
- NCT07415941 — MBM and taVNS for Low Back Pain and Depressive Symptoms · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03305328 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Florida State University
- Last refreshed: 9 October 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03305328.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing